WO2003094784A2 - Urethral prosthesis with tensioning member - Google Patents

Urethral prosthesis with tensioning member Download PDF

Info

Publication number
WO2003094784A2
WO2003094784A2 PCT/US2003/012743 US0312743W WO03094784A2 WO 2003094784 A2 WO2003094784 A2 WO 2003094784A2 US 0312743 W US0312743 W US 0312743W WO 03094784 A2 WO03094784 A2 WO 03094784A2
Authority
WO
WIPO (PCT)
Prior art keywords
urethral prosthesis
stem
arms
prosthesis
urethral
Prior art date
Application number
PCT/US2003/012743
Other languages
French (fr)
Other versions
WO2003094784A3 (en
Inventor
Steven W. Siegel
Kevin R. Arnal
Robert E. Lund
Kimberly A. Anderson
Brian P. Watschke
Original Assignee
Ams Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ams Research Corporation filed Critical Ams Research Corporation
Priority to CA002483124A priority Critical patent/CA2483124A1/en
Priority to EP03728522A priority patent/EP1503695A2/en
Priority to BR0309802-8A priority patent/BR0309802A/en
Priority to JP2004502874A priority patent/JP2005524484A/en
Priority to AU2003234212A priority patent/AU2003234212A1/en
Priority to KR10-2004-7017005A priority patent/KR20050010765A/en
Publication of WO2003094784A2 publication Critical patent/WO2003094784A2/en
Publication of WO2003094784A3 publication Critical patent/WO2003094784A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A61F2/0045Support slings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0057Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0078Gender-specific, e.g. different for male and female patients

Definitions

  • Urinary incontinence is a condition characterized by involuntary loss of urine beyond the individual's control.
  • One cause for this loss of control is damage to the urethral sphincter caused by, for example, prostatectomy, radiation therapy or pelvic accidents.
  • Other causes of incontinence include bladder instability, over-flowing incontinence and fistulas.
  • an Artificial Urinary Sphincter e.g. AMS Sphincter 800 available from American Medical Systems, Minnetonka, Mfc
  • a bone-screw fixated male sling e.g.
  • AMS InVance available from American Medical Systems
  • Other procedures that have been largely discontinued include the implantation of a Kaufman III Prosthesis beneath the urethra. All of these prostheses exert a pressure on the urethra to prevent unintentional voiding of the bladder.
  • a drawback to these aforementioned techniques relates to tensioning. After implantation of the InVance male sling, for example, any adjustments to the pressure exerted on the urethra by the prosthesis must be performed during a separate procedure. To adjust the Artificial Urinary Sphincter, additional instrumentation may also be required. These additional procedures may subject the patient to increased risk of infection and may also make the procedure more costly. An additional drawback is that these devices have little tolerance for improvement or deterioration in the patient's incontinence condition. Thus, minor changes in the patient's condition may require another surgical procedure.
  • the present invention provides a urethral prosthesis including a first arm, a second arm and a stem.
  • the first and second arms meet or join to define a junction that is adapted to exert sufficient pressure on a portion of a patient's urethra to prevent unintentional voiding of a patient's bladder.
  • the stem is joined to the junction such that a tension force may be exerted on the stem to reduce the pressure exerted on the portion of the patient's urethra by the junction such that the patient's bladder may be voided.
  • the urethral prosthesis may further include a tensioning member associated with the first arm, second arm and/or stem, which may be adapted to facilitate manipulation of the urethral prosthesis during implantation in a patient.
  • the present invention provides a method of treating urinary incontinence, in which a prosthesis as described herein is implanted into a patient.
  • the first and second arms may be internally oriented in a variety of manners.
  • the first and second aims may be oriented or positioned anterior, posterior or transobturator relative to the patient's pubic symphysis.
  • the junction contacts a portion of the urethra and exerts a sufficient pressure to prevent unintentional voiding of the patient's bladder.
  • the stem may be positioned or implanted in the patient's scrotum to facilitate easy patient access.
  • the urethral prosthesis of the present invention may be secured by tissue in-growth and/or tissue encapsulation of portions of the prosthesis.
  • Figure 1 schematically illustrates a perspective view of an embodiment of the present invention.
  • Figure 2 schematically illustrates a perspective view of an embodiment of the present invention.
  • Figure 3 schematically illustrates a perspective view of an embodiment of the present invention.
  • FIGS 4a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
  • FIGS 5a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
  • Figures 6a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
  • Figures 7a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
  • Figures 8a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
  • Figures 9a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
  • FIGS 1-3 illustrate a urethral prosthesis 10 according to various embodiments of the present invention.
  • Urethral prosthesis 10 includes a first arm 20 and a second arm 30 that join to form a junction 40.
  • a stem 50 is further joined to the junction 40.
  • the first and second arms 20, 30 may include one or more lengths of flexible, longitudinally extendable material.
  • the material may be inelastic or elastic, longitudinally extendable or non-extendable, and may be patterned, for example in a mesh pattern, which may encourage tissue in-growth.
  • Suitable materials for the first and second arms 20, 30 may include, but are not limited to materials such as polyester, polypropylene, nylon, polyethylene terephthalate, polytefrafluorethylene, expanded polytetrafluoroethylene, polyvinylidene fluoride, polyamide and silk, as well as derivatives, combinations and hybrids of these materials.
  • the end portions of the first and second arms 20, 30 may be configured, for example as a mesh, to promote tissue in-growth.
  • the first and second arms 20, 30 may be at least partially formed from a bioabsorbable material such as polylactic acid or polyglycolic acid. Suitable materials are also reported in U.S. Published Patent Application No. 2002/0147382.
  • the urethral prosthesis 10 may be coated with a suitable bioactive material having a desired physiological effect.
  • suitable bioactive materials may be selectively coated on desired areas or portions of the urethral prosthesis 10 to reduce inflammation, encourage tissue in-growth and/or to prevent infection in specific areas of a patient.
  • the first and second arms 20, 30 include portions having a polymeric mesh coated with a silicone material or other suitable material, including but not limited to an elastomer, polypropylene, polyester, polyurethane, polyamide, or a derivative, combination or hybrid thereof.
  • portions of the first and second arms 20, 30 may include an additional coating or tubing.
  • tubes 25, 35 encompass or surround portions of the first and second arms 20, 30. Tubes 25, 35 may be used, for example, when the first and second arms 20, 30 are formed from a longitudinally extensible mesh. The tubes 25, 35 may allow longitudinal extension of the mesh within the tube independent of the mesh outside of the tube.
  • Suitable materials for the tubes 25, 35 may include, but are not limited to polypropylene, nylon, polyester, polytetrafluoroethylene, polyvinyl chloride, polyamide, and derivatives, combinations and hybrids thereof.
  • the first and second arms 20, 30 may be formed from discrete lengths of materials, which are attached or joined at respective proximal ends by a variety of suitable methods to form the junction 40.
  • the first and second arms 20, 30 may be formed from a single length of material such that the junction 40 is formed approximately at a center point of the length of material that forms the first and second arms 20, 30.
  • the first and second arms 20, 30 may be sized and shaped for internal implantation and attachment in the vicinity of a patient's pubic symphysis, as reported in further detail below.
  • the arms 20, 30 may each have a length between about 5 and about 30 cm, more particularly between about 15 and about 25 cm.
  • the arms 20, 30 may have a width of between about 0.5 and about 5 cm, more particularly between about 0.5 cm and about 2.5 cm. Additionally, the width of the first and second arms 20, 30 may not be uniform.
  • the first and second arms 20, 30 join to form the junction 40.
  • the junction 40 is adapted to exert sufficient pressure on a patient's urethra to prevent unintentional voiding.
  • the junction 40 may include portions that are wider than the first and second arms 20, 30.
  • the junction 40 may have a portion between about 3 and about 5 cm long and between about 1 and about 2 cm wide that is adapted to exert a force against a patient's urethra when implanted.
  • the junction includes a coating or overcoat 45 covering proximal portions of first and second arms 20, 30.
  • the overcoat 45 may function to secure the first and second arms 20, 30 together.
  • the overcoat 45 of the junction may extend between about 1 and about 5 cm along the first and second arms 20, 30, more particularly between about 1 and about 3 cm.
  • the overcoat 45 may have a thickness of between about 0.15 mm and about 3 mm, more particularly between about 0.5 mm and about 1.5 mm.
  • Suitable overcoat materials include, but are not limited to, polymeric materials such as elastomers, silicones, polypropylenes, polyesters, polyurethanes, polyvinyl chlorides, polyamides and derivatives, combinations and hybrids thereof.
  • the overcoat 45 may discourage tissue in-growth in the vicinity of the patient's urethra, while allowing tissue encapsulation. Tissue encapsulation may allow some degree of movement of the junction 40.
  • the junction 40 may include a compression member (not shown) secured to the first and second arms.
  • the compression member may include a rigid or flexible material that is adapted to exert pressure against a portion of a patient's urethra to prevent unintentional voiding of the patient's bladder.
  • the compression member may include a resilient pillow or pouch positioned to exert a pressure against a portion of a patient's urethra.
  • the stem 50 is joined to the first and second arms 20, 30 at the junction 40.
  • the stem 50 may be formed from the same types of materials as the first and second arms 20, 30. However, the stem 50 is generally formed from a material that has low elasticity such that the stem 50 does not significantly stretch upon the exertion of a tension force.
  • the stem 50 may be formed from a discrete length of material, or may be formed from a single length of material including the first arm 20 and/or second arm 30 of the prosthesis 10.
  • a portion of the stem 50 may also include the overcoat 45 formed at the junction 40.
  • the overcoat 45 may extend between about 0.25 and about 3 cm, more particularly between about 0.5 and about 1 cm along a proximal portion of the stem.
  • the overcoat 45 may attach or join the discrete lengths of material together at the junction 40.
  • a stem 55 may include a filament 57 and a tab 59.
  • the filament should be capable of withstanding the exertion of a tension force on the tab 59.
  • the urethral prosthesis 10 of the present invention may also include one or more tensioning members 60, 70, 80, which are associated with the urethral prosthesis.
  • the one or more tensioning members 60, 70, 80 may be secured to one or both of the first and second arms 20, 30 and may also be optionally secured to the stem 50.
  • the tensioning member generally functions to provide uniform movement of the urethral prosthesis 10, particularly the first and second arms 20, 30 during implantation in a patient such that suitable pressure is exerted on a patient's urethra by the junction 40.
  • the tensioning member includes at least one filament. In the embodiment illustrated in Figs.
  • the tensioning member 60, 70, 80 includes a first filament 60 secured to the first arm 20, a second filament 70 secured to the second arm 30 and a third filament 80 secured to the stem 50. More particularly, each filament may be independently secured to a distal end of the first arm 20, second arm 30 and/or the stem 50. Each filament may also be secured at a proximal end of the first arm 20, second arm 30, and/or stem 50, as well as the junction 40. In one embodiment, the first, second and third filaments 60, 70, 80 are secured to at least one of the other filaments 60, 70, 80 at the junction 40. In another embodiment, the first, second and third filaments 60, 70, 80 are secured to dilators 100, 110, 120.
  • One or more dilators 100, 110 and 120 may be secured to the distal ends of the first and second arms 20, 30 and/or the stem 50 to facilitate implantation in a patient. More particularly, the dilators 100, 110 and 120 may associate the urethral prosthesis 10 to a guide needle, which may be used to position and/or orient the urethral prosthesis 10, as reported in greater detail below.
  • the urethral prosthesis 10 may be implanted in a patient by a variety of suitable methods.
  • a small transverse scrotal incision and one or two small horizontal suprapubic incisions are made.
  • a suitable guide needle similar to the needles reported in U.S. Published Patent Application Nos. 2002/0147382, 2002/0099259 Al, 2002/0099258 Al and/or 2001/0161382 maybe inserted into the first suprapubic incision and passed either anterior or superior to the pubic symphysis and towards the scrotal incision.
  • a second guide needle may be inserted through the optional second suprapubic incision and positioned and/or guided in a similar manner, in opposition to the first needle.
  • the distal ends of the guide needles may then be secured to the dilators 100 and 110, and the urethral prosthesis 10 may be pulled up through the suprapubic incisions.
  • a third guide needle may be used to insert the stem 50 into the scrotal incision and to guide the stem 50 into the proper location and orientation within the scrotum.
  • the stem 50 may be positioned at the posterior scrotal midline of the patient.
  • first and second arms 20, 30 and/or the stem 50 may be covered with heat sealed plastic sheaths (not shown), which are removed prior to completing the procedure.
  • the sheath is heat sealed to first and second arms 20, 30 and stem 50, and the plastic sheath forms the connection to the connectors 100, 110 and 120.
  • the urethral prosthesis 10 may then be positioned in the vicinity of a patient's descending rami of the pubic bone such that the junction 40 contacts a portion of the patient's urethra. The pressure exerted on the urethra may be adjusted during implantation.
  • the pressure may be increased by pulling on the distal ends of the first and second arms 20, 30 until a sufficient force is exerted on the urethra.
  • the pressure may be reduc ⁇ d by exerting downward tension on the junction 40 or the stem 50.
  • the tensioning members 60, 70, 80 may facilitate these tension adjustments to the urethral prosthesis by allowing the prosthesis to be manipulated in a uniform fashion, rather than by having certain portions of the prosthesis move while other portions remain immobile.
  • the tensioning members may be removed prior to completing the implantation procedure, or may remain secured to the urethral prosthesis substantially permanently.
  • the junction 40 exerts a pressure between about 50 and about 300 cm H 2 O, more particularly, between about 50 and about 140 cm H 2 O, even more particularly, between about 50 and about 70 cm H 2 O on the patient's urethra.
  • the exerted pressure may be higher than in conventional prostheses because the pressure may be released by exerting tension on the stem as reported in greater detail below.
  • the urethral prosthesis 10 may be secured internally within the patient in a variety of suitable manners. In one embodiment, the urethral prosthesis 10 maybe secured solely by tissue in-growth and/or tissue encapsulation. More specifically, portions of the first and second arms, 20, 30 and/or the stem 50 may be configured, for example, in a mesh configuration, to encourage tissue in-growth.
  • portions including the junction 50 and/or portions of the first and second arms, may be configured in a manner that does not promote tissue in-growth, but allows for tissue encapsulation.
  • portions of the urethral prosthesis 10 may become increasingly secured within the patient by tissue ingrowth and/or tissue encapsulation.
  • this embodiment does not require (but may include) additional bone or soft tissue anchors to further secure the urethral prosthesis 10.
  • the first and second arms may be secured to a soft tissue region, such as at the obturator internus muscles or the gracilis muscles, with a combination of suitable soft tissue anchors and sutures.
  • a combination of tissue in-grown portions and suitable anchors may secure the urethral prosthesis 10.
  • the first and second arms 20, 30 may be secured to a suitable portion of the patient's descending rami by a combination of anchors and sutures as reported.
  • the urethral prosthesis 10 may be secured to the pelvic origin of the gracilis tendon.
  • a tissue anchor may be implanted in the most proximal position to the inferior pubic ramus, where the gracilis tendon attaches to the bone. After the tissue anchor is inserted lateral to the tendon, a suture may be passed medial through the tendon to secure the prosthesis in place. This technique may be used on both sides of the body in opposition to secure the urethral prosthesis 10.
  • a variety of suitable tissue anchor designs and materials may be used for securing the urethral prosthesis 10 in this embodiment, hi one embodiment, for example, a "T" shaped tissue anchor may be formed from titanium, plastic, or stainless steel and may be deployed with a suitable deployment tool and attached to a suture to secure the sling to the tissue.
  • one or more tissue anchors may be used to secure the urethral prosthesis to the obturator internus muscles.
  • the anchor may be deployed through the obturator foramen and pass through the obturator externus muscle to the obturator internus muscle.
  • the anchor may then be positioned in the anterior recess of the ischio-anal fossa, just anterior to the obturator internus muscle.
  • At least one anchor in each obturator internus muscle in opposition may be used to secure the sling in place.
  • the urethral prosthesis 10 may be secured in this position by screwing a bone screw proximal to the gracilis tendon into the inferior pubic ramus.
  • the urethral prosthesis may be secured to the superior or inferior pubic rami with a bone screw.
  • Figures 4-9 illustrate several implantation orientations for the urethral prosthesis 10.
  • Figures 4 and 5 illustrate an anterior pubic symphysis orientation, in which the first and second arms 20, 30 extend anterior to the pubic symphysis 150. This orientation may be beneficial because of the reduced chance of causing vascular, neural or visceral damage during implantation.
  • the junction 40 is positioned to exert pressure on a proximal portion 185 of the patient's urethra 170.
  • the junction 40 is positioned to exert pressure on a distal portion 195 of the patient's urethra 170.
  • Figures 6a-b illustrate a posterior pubic symphysis orientation, in which first and second arms 20, 30 extend posterior to the pubic symphysis 150. In this orientation, the junction 40 exerts pressure on the proximal portion 185 of the patient's urethra 170.
  • Figures 7a-b, 8a-b and 9a-b illustrate various transobturator orientations, in which the first and second arms 29, 30 extend around the pubic rami.
  • the prosthesis of the present invention exerts sufficient force upon a portion of the patient's urethra to prevent unintentional voiding of the patient's bladder.
  • the junction 40 is lifted away from the urethra so that the pressure exerted on the urethra is reduced to a sufficient extent that the patient's bladder may be intentionally voided.
  • the overcoat 45 of the junction 40 is encapsulated by (but not in-grown with) tissue, the junction 40 may be manipulated to a sufficient degree to allow voiding, without adversely affecting the orientation or attachment of the urethral prosthesis 10.
  • the tension on the stem 50 may be released to allow the junction 40 to exert pressure on a portion of the-urethra to prevent subsequent unintentional bladder voiding.
  • the urethral prosthesis of the present invention provides several benefits.
  • the prosthesis may be implanted in a variety of orientations in a patient.
  • the prosthesis may include portions that encourage tissue in-growth and portions that allow for tissue encapsulation. This may provide for some degree of movement in desired areas, such as the junction, while still maintaining sufficient attachment in the patient without requiring additional bone and/or soft tissue anchors.
  • the addition of the stem allows the patient's bladder to be voided by simply exerting tension on the stem. This may allow the prosthesis to exert a higher pressure on a portion of the' patient's urethra then existing devices that do not allow for patient manipulation.

Abstract

Urethral prosthesis (10) including a first and a second arm (20, 30) that join to form a junction (40), and a stem (50) that is also joined to the junction (40). The junction (40) is adapted to exert sufficient pressure on a portion of a patient's urethra to prevent unintentional voiding of the patient's bladder. However, upon exerting a tension force on the stem (50), the pressure exerted by the junction (40) is reduced such that the patient's bladder may be intentionally voided.

Description

MALE URETHRAL PROSTHESIS WITH TENSIONING MEMBER
BACKGROUND OF THE INVENTION Urinary incontinence is a condition characterized by involuntary loss of urine beyond the individual's control. One cause for this loss of control is damage to the urethral sphincter caused by, for example, prostatectomy, radiation therapy or pelvic accidents. Other causes of incontinence include bladder instability, over-flowing incontinence and fistulas. Currently, there are a few known surgical treatments for male incontinence, including the implantation of an Artificial Urinary Sphincter (e.g. AMS Sphincter 800 available from American Medical Systems, Minnetonka, Mfc), the implantation of a bone-screw fixated male sling (e.g. AMS InVance, available from American Medical Systems), and a few other procedures. Other procedures that have been largely discontinued include the implantation of a Kaufman III Prosthesis beneath the urethra. All of these prostheses exert a pressure on the urethra to prevent unintentional voiding of the bladder.
A drawback to these aforementioned techniques relates to tensioning. After implantation of the InVance male sling, for example, any adjustments to the pressure exerted on the urethra by the prosthesis must be performed during a separate procedure. To adjust the Artificial Urinary Sphincter, additional instrumentation may also be required. These additional procedures may subject the patient to increased risk of infection and may also make the procedure more costly. An additional drawback is that these devices have little tolerance for improvement or deterioration in the patient's incontinence condition. Thus, minor changes in the patient's condition may require another surgical procedure.
SUMMARY OF THE INVENTION
In one embodiment, the present invention provides a urethral prosthesis including a first arm, a second arm and a stem. The first and second arms meet or join to define a junction that is adapted to exert sufficient pressure on a portion of a patient's urethra to prevent unintentional voiding of a patient's bladder. The stem is joined to the junction such that a tension force may be exerted on the stem to reduce the pressure exerted on the portion of the patient's urethra by the junction such that the patient's bladder may be voided. The urethral prosthesis may further include a tensioning member associated with the first arm, second arm and/or stem, which may be adapted to facilitate manipulation of the urethral prosthesis during implantation in a patient.
In another embodiment, the present invention provides a method of treating urinary incontinence, in which a prosthesis as described herein is implanted into a patient. The first and second arms may be internally oriented in a variety of manners. For example, the first and second aims may be oriented or positioned anterior, posterior or transobturator relative to the patient's pubic symphysis. The junction contacts a portion of the urethra and exerts a sufficient pressure to prevent unintentional voiding of the patient's bladder. The stem may be positioned or implanted in the patient's scrotum to facilitate easy patient access. When manual tension is placed on the stem, the pressure exerted on the portion of the urethra by the junction decreases such that the patient's bladder may be intentionally voided. After voiding, the tension may be released such that the junction once again exerts sufficient pressure on the portion of the urethra to prevent unintentional voiding of the patient's bladder. Advantageously, the urethral prosthesis of the present invention may be secured by tissue in-growth and/or tissue encapsulation of portions of the prosthesis.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 schematically illustrates a perspective view of an embodiment of the present invention.
Figure 2 schematically illustrates a perspective view of an embodiment of the present invention. Figure 3 schematically illustrates a perspective view of an embodiment of the present invention.
Figures 4a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
Figures 5a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
Figures 6a-b illustrate an implanted prosthesis according to an embodiment of the present invention. Figures 7a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
Figures 8a-b illustrate an implanted prosthesis according to an embodiment of the present invention. Figures 9a-b illustrate an implanted prosthesis according to an embodiment of the present invention.
DETAILED DESCRIPTION
Figures 1-3 illustrate a urethral prosthesis 10 according to various embodiments of the present invention. Urethral prosthesis 10 includes a first arm 20 and a second arm 30 that join to form a junction 40. A stem 50 is further joined to the junction 40.
A wide range of suitable materials or combinations of suitable materials may be used to form the first and second arms 20, 30. The first and second arms 20, 30 in the illustrated embodiment may include one or more lengths of flexible, longitudinally extendable material. The material may be inelastic or elastic, longitudinally extendable or non-extendable, and may be patterned, for example in a mesh pattern, which may encourage tissue in-growth. Suitable materials for the first and second arms 20, 30 may include, but are not limited to materials such as polyester, polypropylene, nylon, polyethylene terephthalate, polytefrafluorethylene, expanded polytetrafluoroethylene, polyvinylidene fluoride, polyamide and silk, as well as derivatives, combinations and hybrids of these materials. Preferably, at least the end portions of the first and second arms 20, 30 may be configured, for example as a mesh, to promote tissue in-growth. Alternatively, the first and second arms 20, 30 may be at least partially formed from a bioabsorbable material such as polylactic acid or polyglycolic acid. Suitable materials are also reported in U.S. Published Patent Application No. 2002/0147382. Still further, the urethral prosthesis 10 may be coated with a suitable bioactive material having a desired physiological effect. For example, t suitable bioactive materials may be selectively coated on desired areas or portions of the urethral prosthesis 10 to reduce inflammation, encourage tissue in-growth and/or to prevent infection in specific areas of a patient. In one embodiment, the first and second arms 20, 30 include portions having a polymeric mesh coated with a silicone material or other suitable material, including but not limited to an elastomer, polypropylene, polyester, polyurethane, polyamide, or a derivative, combination or hybrid thereof. In an alternate embodiment, portions of the first and second arms 20, 30 may include an additional coating or tubing. For example, in the embodiment illustrated in Figure 2, tubes 25, 35 encompass or surround portions of the first and second arms 20, 30. Tubes 25, 35 may be used, for example, when the first and second arms 20, 30 are formed from a longitudinally extensible mesh. The tubes 25, 35 may allow longitudinal extension of the mesh within the tube independent of the mesh outside of the tube. Suitable materials for the tubes 25, 35 may include, but are not limited to polypropylene, nylon, polyester, polytetrafluoroethylene, polyvinyl chloride, polyamide, and derivatives, combinations and hybrids thereof. The first and second arms 20, 30 may be formed from discrete lengths of materials, which are attached or joined at respective proximal ends by a variety of suitable methods to form the junction 40. Alternatively, the first and second arms 20, 30 may be formed from a single length of material such that the junction 40 is formed approximately at a center point of the length of material that forms the first and second arms 20, 30.
The first and second arms 20, 30 may be sized and shaped for internal implantation and attachment in the vicinity of a patient's pubic symphysis, as reported in further detail below. In one embodiment, the arms 20, 30 may each have a length between about 5 and about 30 cm, more particularly between about 15 and about 25 cm. The arms 20, 30 may have a width of between about 0.5 and about 5 cm, more particularly between about 0.5 cm and about 2.5 cm. Additionally, the width of the first and second arms 20, 30 may not be uniform.
The first and second arms 20, 30 join to form the junction 40. The junction 40 is adapted to exert sufficient pressure on a patient's urethra to prevent unintentional voiding. The junction 40 may include portions that are wider than the first and second arms 20, 30. For example, the junction 40 may have a portion between about 3 and about 5 cm long and between about 1 and about 2 cm wide that is adapted to exert a force against a patient's urethra when implanted. In one embodiment, the junction includes a coating or overcoat 45 covering proximal portions of first and second arms 20, 30. In embodiments in which the first and second arms 20, 30 are formed from discrete lengths of material, the overcoat 45 may function to secure the first and second arms 20, 30 together. The overcoat 45 of the junction may extend between about 1 and about 5 cm along the first and second arms 20, 30, more particularly between about 1 and about 3 cm. The overcoat 45 may have a thickness of between about 0.15 mm and about 3 mm, more particularly between about 0.5 mm and about 1.5 mm. Suitable overcoat materials include, but are not limited to, polymeric materials such as elastomers, silicones, polypropylenes, polyesters, polyurethanes, polyvinyl chlorides, polyamides and derivatives, combinations and hybrids thereof. The overcoat 45 may discourage tissue in-growth in the vicinity of the patient's urethra, while allowing tissue encapsulation. Tissue encapsulation may allow some degree of movement of the junction 40.
In an alternate embodiment, the junction 40 may include a compression member (not shown) secured to the first and second arms. The compression member may include a rigid or flexible material that is adapted to exert pressure against a portion of a patient's urethra to prevent unintentional voiding of the patient's bladder. For example, the compression member may include a resilient pillow or pouch positioned to exert a pressure against a portion of a patient's urethra.
Stem 50 is joined to the first and second arms 20, 30 at the junction 40. The stem 50 may be formed from the same types of materials as the first and second arms 20, 30. However, the stem 50 is generally formed from a material that has low elasticity such that the stem 50 does not significantly stretch upon the exertion of a tension force. The stem 50 may be formed from a discrete length of material, or may be formed from a single length of material including the first arm 20 and/or second arm 30 of the prosthesis 10. A portion of the stem 50 may also include the overcoat 45 formed at the junction 40. For example, the overcoat 45 may extend between about 0.25 and about 3 cm, more particularly between about 0.5 and about 1 cm along a proximal portion of the stem. In embodiments in which the first and/or second arms 20, 30 and the stem 50 include discrete lengths of material, the overcoat 45 may attach or join the discrete lengths of material together at the junction 40.
In an alternate embodiment illustrated in Fig. 3, a stem 55 may include a filament 57 and a tab 59. The filament should be capable of withstanding the exertion of a tension force on the tab 59.
The urethral prosthesis 10 of the present invention may also include one or more tensioning members 60, 70, 80, which are associated with the urethral prosthesis. The one or more tensioning members 60, 70, 80 may be secured to one or both of the first and second arms 20, 30 and may also be optionally secured to the stem 50. As described in greater detail below, the tensioning member generally functions to provide uniform movement of the urethral prosthesis 10, particularly the first and second arms 20, 30 during implantation in a patient such that suitable pressure is exerted on a patient's urethra by the junction 40. In one embodiment, the tensioning member includes at least one filament. In the embodiment illustrated in Figs. 1 and 2, the tensioning member 60, 70, 80 includes a first filament 60 secured to the first arm 20, a second filament 70 secured to the second arm 30 and a third filament 80 secured to the stem 50. More particularly, each filament may be independently secured to a distal end of the first arm 20, second arm 30 and/or the stem 50. Each filament may also be secured at a proximal end of the first arm 20, second arm 30, and/or stem 50, as well as the junction 40. In one embodiment, the first, second and third filaments 60, 70, 80 are secured to at least one of the other filaments 60, 70, 80 at the junction 40. In another embodiment, the first, second and third filaments 60, 70, 80 are secured to dilators 100, 110, 120.
One or more dilators 100, 110 and 120 may be secured to the distal ends of the first and second arms 20, 30 and/or the stem 50 to facilitate implantation in a patient. More particularly, the dilators 100, 110 and 120 may associate the urethral prosthesis 10 to a guide needle, which may be used to position and/or orient the urethral prosthesis 10, as reported in greater detail below.
The urethral prosthesis 10 may be implanted in a patient by a variety of suitable methods. In one embodiment, a small transverse scrotal incision and one or two small horizontal suprapubic incisions are made. A suitable guide needle, similar to the needles reported in U.S. Published Patent Application Nos. 2002/0147382, 2002/0099259 Al, 2002/0099258 Al and/or 2001/0161382 maybe inserted into the first suprapubic incision and passed either anterior or superior to the pubic symphysis and towards the scrotal incision. Once a first guide needle has been successfully guided and/or positioned, a second guide needle may be inserted through the optional second suprapubic incision and positioned and/or guided in a similar manner, in opposition to the first needle. The distal ends of the guide needles may then be secured to the dilators 100 and 110, and the urethral prosthesis 10 may be pulled up through the suprapubic incisions. A third guide needle may be used to insert the stem 50 into the scrotal incision and to guide the stem 50 into the proper location and orientation within the scrotum. For example, the stem 50 may be positioned at the posterior scrotal midline of the patient. During the implantation procedure, the first and second arms 20, 30 and/or the stem 50 may be covered with heat sealed plastic sheaths (not shown), which are removed prior to completing the procedure. In one embodiment, the sheath is heat sealed to first and second arms 20, 30 and stem 50, and the plastic sheath forms the connection to the connectors 100, 110 and 120. The urethral prosthesis 10 may then be positioned in the vicinity of a patient's descending rami of the pubic bone such that the junction 40 contacts a portion of the patient's urethra. The pressure exerted on the urethra may be adjusted during implantation. For example, the pressure may be increased by pulling on the distal ends of the first and second arms 20, 30 until a sufficient force is exerted on the urethra. Alternatively, the pressure may be reducέd by exerting downward tension on the junction 40 or the stem 50. The tensioning members 60, 70, 80 may facilitate these tension adjustments to the urethral prosthesis by allowing the prosthesis to be manipulated in a uniform fashion, rather than by having certain portions of the prosthesis move while other portions remain immobile. The tensioning members may be removed prior to completing the implantation procedure, or may remain secured to the urethral prosthesis substantially permanently. In one embodiment, the junction 40 exerts a pressure between about 50 and about 300 cm H2O, more particularly, between about 50 and about 140 cm H2O, even more particularly, between about 50 and about 70 cm H2O on the patient's urethra. Advantageously, the exerted pressure may be higher than in conventional prostheses because the pressure may be released by exerting tension on the stem as reported in greater detail below. The urethral prosthesis 10 may be secured internally within the patient in a variety of suitable manners. In one embodiment, the urethral prosthesis 10 maybe secured solely by tissue in-growth and/or tissue encapsulation. More specifically, portions of the first and second arms, 20, 30 and/or the stem 50 may be configured, for example, in a mesh configuration, to encourage tissue in-growth. Other portions, including the junction 50 and/or portions of the first and second arms, may be configured in a manner that does not promote tissue in-growth, but allows for tissue encapsulation. During the weeks and months after implantation, portions of the urethral prosthesis 10 may become increasingly secured within the patient by tissue ingrowth and/or tissue encapsulation. In this manner, portions that are in-grown with tissue secure the urethral prosthesis 10, while portions that are encapsulated in tissue allow for some movement of portions of the urethral prosthesis 10 during use. Advantageously, this embodiment does not require (but may include) additional bone or soft tissue anchors to further secure the urethral prosthesis 10.
In an alternate embodiment, the first and second arms may be secured to a soft tissue region, such as at the obturator internus muscles or the gracilis muscles, with a combination of suitable soft tissue anchors and sutures. In an additional embodiment, a combination of tissue in-grown portions and suitable anchors may secure the urethral prosthesis 10. In yet another embodiment, as in U.S. Published Patent Application No. 2002/10752, the first and second arms 20, 30 may be secured to a suitable portion of the patient's descending rami by a combination of anchors and sutures as reported. In yet another embodiment, the urethral prosthesis 10 may be secured to the pelvic origin of the gracilis tendon. For example, a tissue anchor may be implanted in the most proximal position to the inferior pubic ramus, where the gracilis tendon attaches to the bone. After the tissue anchor is inserted lateral to the tendon, a suture may be passed medial through the tendon to secure the prosthesis in place. This technique may be used on both sides of the body in opposition to secure the urethral prosthesis 10. A variety of suitable tissue anchor designs and materials may be used for securing the urethral prosthesis 10 in this embodiment, hi one embodiment, for example, a "T" shaped tissue anchor may be formed from titanium, plastic, or stainless steel and may be deployed with a suitable deployment tool and attached to a suture to secure the sling to the tissue. In an alternate embodiment, one or more tissue anchors may be used to secure the urethral prosthesis to the obturator internus muscles. The anchor may be deployed through the obturator foramen and pass through the obturator externus muscle to the obturator internus muscle. The anchor may then be positioned in the anterior recess of the ischio-anal fossa, just anterior to the obturator internus muscle. At least one anchor in each obturator internus muscle in opposition may be used to secure the sling in place. In a further embodiment, the urethral prosthesis 10 may be secured in this position by screwing a bone screw proximal to the gracilis tendon into the inferior pubic ramus. Alternatively, the urethral prosthesis may be secured to the superior or inferior pubic rami with a bone screw.
Figures 4-9 illustrate several implantation orientations for the urethral prosthesis 10. Figures 4 and 5 illustrate an anterior pubic symphysis orientation, in which the first and second arms 20, 30 extend anterior to the pubic symphysis 150. This orientation may be beneficial because of the reduced chance of causing vascular, neural or visceral damage during implantation. In Figures 4a-b, the junction 40 is positioned to exert pressure on a proximal portion 185 of the patient's urethra 170. In Figures 5a-b, the junction 40 is positioned to exert pressure on a distal portion 195 of the patient's urethra 170.
Figures 6a-b illustrate a posterior pubic symphysis orientation, in which first and second arms 20, 30 extend posterior to the pubic symphysis 150. In this orientation, the junction 40 exerts pressure on the proximal portion 185 of the patient's urethra 170. Figures 7a-b, 8a-b and 9a-b illustrate various transobturator orientations, in which the first and second arms 29, 30 extend around the pubic rami.
After implantation, the prosthesis of the present invention exerts sufficient force upon a portion of the patient's urethra to prevent unintentional voiding of the patient's bladder. However, when a sufficient tension force is exerted on the stem 50, the junction 40 is lifted away from the urethra so that the pressure exerted on the urethra is reduced to a sufficient extent that the patient's bladder may be intentionally voided. Importantly, because the overcoat 45 of the junction 40 is encapsulated by (but not in-grown with) tissue, the junction 40 may be manipulated to a sufficient degree to allow voiding, without adversely affecting the orientation or attachment of the urethral prosthesis 10. After voiding, the tension on the stem 50 may be released to allow the junction 40 to exert pressure on a portion of the-urethra to prevent subsequent unintentional bladder voiding. The urethral prosthesis of the present invention provides several benefits.
First, the prosthesis may be implanted in a variety of orientations in a patient. Second, the prosthesis may include portions that encourage tissue in-growth and portions that allow for tissue encapsulation. This may provide for some degree of movement in desired areas, such as the junction, while still maintaining sufficient attachment in the patient without requiring additional bone and/or soft tissue anchors. Third, the addition of the stem allows the patient's bladder to be voided by simply exerting tension on the stem. This may allow the prosthesis to exert a higher pressure on a portion of the' patient's urethra then existing devices that do not allow for patient manipulation.

Claims

CLAIMSWhat is claimed is:
1. A urethral prosthesis comprising: a first arm and a second arm that are joined to define a junction adapted to exert pressure on a portion of a urethra when implanted; and a stem joined to the junction that is adapted to decrease the pressure exerted on the portion of the urethra when a tension force is exerted on the stem.
2. The urethral prosthesis of claim 1 wherein the first and second arms comprise a flexible material.
3. The urethral prosthesis of claim 1 wherein the first and second arms comprise a stretchable material.
4. The urethral prosthesis of claim 1 wherein the first and second arms comprise a polymeric material.
5. The urethral prosthesis of claim 1 wherein the first and second arms comprise polyester, polypropylene, nylon, polyethylene terephthalate, polytefrafluorethylene, expanded polytefrafluorethylene, polyvinylidene fluoride, polyamide, silk or combinations or derivatives thereof.
6. The urethral prosthesis of claim 1 wherein the first and second arms comprise a mesh material.
7. The urethral prosthesis of claim 1 wherein the first and second arms comprise a coating.
8. The urethral prosthesis of claim 7 wherein the coating comprises an elastomer, silicone, polypropylene, polyester, polyurethane, polyvinyl chloride, polyamide or derivatives or combinations thereof.
9. The urethral prosthesis of claim 1 wherein the first and second arms are coated with a bioactive material.
10. The urethral prosthesis of claim 1 wherein the first and second arms comprise a silicone material.
11. The urethral prosthesis of claim 1 further comprising a tube encompassing a portion of the first arm.
12. The urethral prosthesis of claim 1 further comprising a tube encompassing a portion of the second arm.
13. The urethral prosthesis of claim 1 wherein the first and second arms are integrally joined.
14. The urethral prosthesis of claim 1 wherein the first and second arms are formed from a single piece of material.
15. The urethral prosthesis of claim 1 wherein the first arm and second arm are joined at respective proximal ends to define the junction.
16. The urethral prosthesis of claim 1 wherein the first and second arms have a width between about 0.5 and about 5 cm.
17. The urethral prosthesis of claim 1 wherein the first and second arms have a width between about 0.5 and about 2.5 cm.
18. The urethral prosthesis of claim 1 wherein the first and second arms have a length of between about 5 and about 30 cm.
19. The urethral prosthesis of claim 1 wherein the stem comprises a flexible material.
20. The urethral prosthesis of claim 1 wherein the stem comprises a stretchable material.
21. The urethral prosthesis of claim 1 wherein the stem comprises a polymeric material.
22. The urethral prosthesis of claim 1 wherein the stem comprises polyester, polypropylene, polyethylene terephthalate, polytetrafluorethylene, expanded polytefrafluorethylene, polyvinylidene fluoride, polyamide, silk or combinations or derivatives thereof.
23. The urethral prosthesis of claim 1 wherein the stem comprises a mesh material.
24. The urethral prosthesis of claim 1 wherein the stem further comprises a coating.
25. The urethral prosthesis of claim 24 wherein the coating comprises an elastomer, silicone, polypropylene, polyester, polyurethane, polyvinyl chloride, polyamide or derivatives or combinations thereof.
26. The urethral prosthesis of claim 1 wherein the stem is coated with a bioactive material.
27. The urethral prosthesis of claim 1 wherein the junction comprises an overcoat covering portions of the first and second arms.
28. The urethral prosthesis of claim 27 wherein the overcoat extends between about 1 and about 5 cm along a proximal end of each of the first and second arms.
29. The urethral prosthesis of claim 27 wherein the overcoat further covers a portion of the stem.
30. The urethral prosthesis of claim 29 wherein the overcoat extends between about 0.25 and about 3 cm along a proximal end of the stem.
31. The urethral prosthesis of claim 27 wherein the overcoat comprises an elastomer, silicone, polypropylene, polyester, polyurethane, polyvinyl chloride, polyamide or derivatives or combinations thereof.
32. The urethral prosthesis of claim 1 further comprising a tensioning member associated with the first and second arms.
33. The urethral prosthesis of claim 32 wherein the tensioning member is further associated with the stem.
34. The urethral prosthesis of claim 32 wherein the tensioning member comprises at least one filament.
35. The urethral prosthesis of claim 34 wherein the tensioning member comprises a first filament secured to the first arm and a second filament secured to the second arm.
36. The urethral prosthesis of claim 35 wherein the tensioning member comprises a third filament secured to the stem.
37. The urethral prosthesis of claim 34 wherein each of the at least one filament is secured to a proximal end of the first arm, second arm or stem.
38. The urethral prosthesis of claim 34 wherein each of the at least one filament is secured to a distal end of the first arm, second arm or stem.
39. The urethral prosthesis of claim 34 wherein the at least one filament is secured at the junction.
40. The urethral prosthesis of claim 1 further comprising a dilator attached to a distal end of each of the first and second arms.
41. The urethral prosthesis of claim 40 further comprising a dilator attached to a distal end of the stem.
42. A method for treating urinary incontinence comprising: implanting into a patient a urethral prosthesis comprising a first arm and a second arm that are joined to define a junction that exerts pressure on a portion of a patient's urethra, and a stem joined to the junction; exerting tension on the stem to decrease the pressure exerted on the portion of the urethra; voiding the patient's bladder; and releasing the tension exerted on the stem such that the junction exerts a pressure on the portion of the urethra.
43. The method of claim 42 wherein the junction exerts a pressure of between about 50 and about 300 cm H2O on the portion of the patient's urethra.
44. The method of claim 42 wherein the junction exerts a pressure of between about 50 and about 140 cm H2O on the portion of the patient's urethra.
45. The method of claim 42 wherein the junction exerts a pressure of between about 50 and about 70 cm H2O on the portion of the patient's urethra.
46. The method of claim 42 wherein the first ana second arms are oriented anterior to the pubic symphysis.
47. The method of claim 42 wherein the first and second arms are oriented posterior to the pubic symphysis.
48. The method of claim 42 wherein the first and second arms are oriented transobturator to the pubic symphysis.
49. The method of claim 42 wherein the stem is implanted in a scrotum.
50. The method of claim 42 wherein the urethral prosthesis is secured to tissue in a patient.
51. The method of claim 50 wherein the urethral prosthesis is secured by tissue in-growth of portions of the first arm, second arm or stem.
52. The method of claim 50 wherein the urethral prosthesis is secured by at least one tissue anchor.
53. The method of claim 50 wherein the urethral prosthesis is secured by at least one soft tissue anchor.
54. The method of claim 50 wherein the urethral prosthesis is secured by at least one bone anchor.
55. The method of claim 50 wherein the urethral prosthesis is secured by tissue in-growth and at least one tissue anchor.
56. The method of claim 50 wherein the first and second arms are secured by at least one suture.
PCT/US2003/012743 2002-05-07 2003-04-24 Urethral prosthesis with tensioning member WO2003094784A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002483124A CA2483124A1 (en) 2002-05-07 2003-04-24 Urethral prosthesis with tensioning member
EP03728522A EP1503695A2 (en) 2002-05-07 2003-04-24 Urethral prosthesis with tensioning member
BR0309802-8A BR0309802A (en) 2002-05-07 2003-04-24 Tension limb male urethral prosthesis
JP2004502874A JP2005524484A (en) 2002-05-07 2003-04-24 Male urethral prosthesis with tensioning member
AU2003234212A AU2003234212A1 (en) 2002-05-07 2003-04-24 Urethral prosthesis with tensioning member
KR10-2004-7017005A KR20050010765A (en) 2002-05-07 2003-04-24 Urethral prosthesis with tensioning member

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37860202P 2002-05-07 2002-05-07
US60/378,602 2002-05-07
US42934102P 2002-11-26 2002-11-26
US60/429,341 2002-11-26

Publications (2)

Publication Number Publication Date
WO2003094784A2 true WO2003094784A2 (en) 2003-11-20
WO2003094784A3 WO2003094784A3 (en) 2004-05-13

Family

ID=29423638

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/012743 WO2003094784A2 (en) 2002-05-07 2003-04-24 Urethral prosthesis with tensioning member

Country Status (8)

Country Link
US (6) US7198597B2 (en)
EP (1) EP1503695A2 (en)
JP (1) JP2005524484A (en)
KR (1) KR20050010765A (en)
AU (1) AU2003234212A1 (en)
BR (1) BR0309802A (en)
CA (1) CA2483124A1 (en)
WO (1) WO2003094784A2 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012653A1 (en) * 2004-08-04 2006-02-09 Ami Agency For Medical Innovations Gmbh Implant for treatment of male urinary stress incontinence
WO2006025950A1 (en) * 2004-08-30 2006-03-09 Boston Scientific Scimed, Inc. Urethral sealing method and device
US7111627B2 (en) 2001-08-27 2006-09-26 Synecor, Llc Satiation devices and methods
US7146984B2 (en) 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
JP2008541792A (en) * 2005-04-30 2008-11-27 コロプラスト アクティーゼルスカブ Implantable sling for the treatment of incontinence and how to use this sling
US7708181B2 (en) 2008-03-18 2010-05-04 Barosense, Inc. Endoscopic stapling devices and methods
US7892292B2 (en) 2001-08-27 2011-02-22 Synecor, Llc Positioning tools and methods for implanting medical devices
US7934631B2 (en) 2008-11-10 2011-05-03 Barosense, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
US7981162B2 (en) 2001-08-27 2011-07-19 Barosense, Inc. Satiation devices and methods
US8029455B2 (en) 2003-01-16 2011-10-04 Barosense, Inc. Satiation pouches and methods of use
US8109895B2 (en) 2006-09-02 2012-02-07 Barosense, Inc. Intestinal sleeves and associated deployment systems and methods
US8568488B2 (en) 2001-08-27 2013-10-29 Boston Scientific Scimed, Inc. Satiation devices and methods
US8961539B2 (en) 2009-05-04 2015-02-24 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US9055942B2 (en) 2005-10-03 2015-06-16 Boston Scienctific Scimed, Inc. Endoscopic plication devices and methods
US9241779B2 (en) 2012-11-02 2016-01-26 Coloplast A/S Male incontinence treatment system
US9314361B2 (en) 2006-09-15 2016-04-19 Boston Scientific Scimed, Inc. System and method for anchoring stomach implant
US9480546B2 (en) 2013-08-05 2016-11-01 Coloplast A/S Hysteropexy mesh apparatuses and methods
US9522000B2 (en) 2013-11-08 2016-12-20 Coloplast A/S System and a method for surgical suture fixation
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US9545249B2 (en) 2007-07-18 2017-01-17 Boston Scientific Scimed, Inc. Overtube introducer for use in endoscopic bariatric surgery
US10098773B2 (en) 2004-04-26 2018-10-16 Boston Scientific Scimed, Inc. Restrictive and/or obstructive implant for inducing weight loss
US10111651B2 (en) 2012-11-02 2018-10-30 Coloplast A/S System and method of anchoring support material to tissue
US10413436B2 (en) 2010-06-13 2019-09-17 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10537456B2 (en) 2007-07-18 2020-01-21 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US11135078B2 (en) 2010-06-13 2021-10-05 Synerz Medical, Inc. Intragastric device for treating obesity

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050010765A (en) * 2002-05-07 2005-01-28 에이엠에스 리써치 코오포레이션 Urethral prosthesis with tensioning member
US8545386B2 (en) 2003-08-14 2013-10-01 Boston Scientific Scimed, Inc. Surgical slings
EP1670381B1 (en) 2003-08-14 2009-09-23 Boston Scientific Limited Surgical slings
US20050247320A1 (en) 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
WO2006015031A2 (en) * 2004-07-28 2006-02-09 Ethicon, Inc. Minimally invasive medical implant and insertion device and method for using the same
US7431690B2 (en) * 2005-04-30 2008-10-07 Coloplast A/S Implantable sling for the treatment of male incontinence and method of using the same
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8864650B2 (en) 2005-06-21 2014-10-21 Ams Research Corporation Methods and apparatus for securing a urethral sling to a pubic bone
WO2007002071A1 (en) 2005-06-21 2007-01-04 Ams Research Corporation Apparatus for securing a urethral sling to pubic bone
US9248010B2 (en) * 2005-07-15 2016-02-02 Boston Scientific Scimed, Inc. Tension-adjustable surgical sling assembly
WO2007016083A1 (en) 2005-07-26 2007-02-08 Ams Research Corporation Methods and systems for treatment of prolapse
JP2009515564A (en) 2005-08-04 2009-04-16 シー・アール・バード・インコーポレイテツド Pelvic implant system and method
IL176883A (en) 2005-09-22 2013-09-30 Eliahu Eliachar Apparatus for the amelioration of urinary incontinence in females
US7878970B2 (en) * 2005-09-28 2011-02-01 Boston Scientific Scimed, Inc. Apparatus and method for suspending a uterus
EP1948073B1 (en) 2005-11-14 2014-03-19 C.R.Bard, Inc. Sling anchor system
US7942806B2 (en) * 2005-12-29 2011-05-17 Ethicon, Inc. Stress urinary incontinence implant and device for deploying same
EP1978890A1 (en) * 2006-01-10 2008-10-15 Hallum, Alton, V Levator for repair of perineal prolapse
US9144483B2 (en) 2006-01-13 2015-09-29 Boston Scientific Scimed, Inc. Placing fixation devices
CA2644983C (en) 2006-03-16 2015-09-29 Boston Scientific Limited System and method for treating tissue wall prolapse
WO2007137226A2 (en) * 2006-05-19 2007-11-29 Ams Research Corporation Method and articles for treatment of stress urinary incontinence
JP4971440B2 (en) 2006-06-16 2012-07-11 エーエムエス リサーチ コーポレイション Surgical implants, tools, and methods for treating pelvic disease
US20090259092A1 (en) * 2006-06-22 2009-10-15 Ogdahl Jason W Adjustable Sling and Method of Treating Pelvic Conditions
AU2007261254B2 (en) * 2006-06-22 2013-12-12 Boston Scientific Scimed, Inc. Adjustable tension incontinence sling assemblies
AU2013211480B2 (en) * 2006-07-16 2015-06-04 Kimberly-Clark Worldwide, Inc. Apparatuses For The Amelioration Of Urinary Incontinence In Females
US8480559B2 (en) 2006-09-13 2013-07-09 C. R. Bard, Inc. Urethral support system
CA2665554A1 (en) * 2006-10-18 2008-04-24 Coloplast A/S Implantable devices for the treatment of incontinence and methods of using the same
US8951185B2 (en) 2007-10-26 2015-02-10 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
US8388514B2 (en) 2006-10-26 2013-03-05 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
WO2008058163A2 (en) 2006-11-06 2008-05-15 Caldera Medical, Inc. Implants and procedures for treatment of pelvic floor disorders
KR100824014B1 (en) * 2007-01-05 2008-04-21 전동호 Apparatus for the treatment of urinary incontinence
US8684907B2 (en) * 2007-02-26 2014-04-01 Jay S. Hortenstine Adjustable incontinence apparatus
US8986188B2 (en) * 2007-04-28 2015-03-24 The Board Of Trustees Of The Leland Stanford Junior University Dynamic and adjustable support devices
AU2008282204B2 (en) * 2007-07-30 2014-04-10 Boston Scientific Scimed, Inc. Apparatus and method for the treatment of stress urinary incontinence
JP2010536419A (en) * 2007-08-14 2010-12-02 カラント, インコーポレイテッド Method and apparatus for supporting, raising or compressing a structure
CA2698558C (en) 2007-09-21 2015-11-17 Ams Research Corporation Pelvic floor treatments and related tools and implants
US8206280B2 (en) 2007-11-13 2012-06-26 C. R. Bard, Inc. Adjustable tissue support member
WO2009086446A1 (en) * 2007-12-28 2009-07-09 Boston Scientific Scimed, Inc. Meshes of variable construction
US9078728B2 (en) 2007-12-28 2015-07-14 Boston Scientific Scimed, Inc. Devices and methods for delivering female pelvic floor implants
US8430807B2 (en) 2007-12-28 2013-04-30 Boston Scientific Scimed, Inc. Devices and methods for treating pelvic floor dysfunctions
US9282958B2 (en) * 2007-12-28 2016-03-15 Boston Scientific Scimed, Inc. Devices and method for treating pelvic dysfunctions
US20090171383A1 (en) 2007-12-31 2009-07-02 David Cole Gastric space occupier systems and methods of use
US8727963B2 (en) 2008-07-31 2014-05-20 Ams Research Corporation Methods and implants for treating urinary incontinence
JP2012500712A (en) 2008-08-25 2012-01-12 エーエムエス リサーチ コーポレイション Implants and methods with minimal invasion
US9017243B2 (en) 2008-08-25 2015-04-28 Ams Research Corporation Minimally invasive implant and method
US8944990B2 (en) 2008-10-27 2015-02-03 Ams Research Corporation Surgical needle and anchor system with retractable features
CA2747608A1 (en) * 2009-01-05 2010-07-08 Caldera Medical, Inc. Implants and procedures for supporting anatomical structures
CA2748894C (en) 2009-02-10 2018-11-13 Ams Research Corporation Surgical articles and methods for treating urinary incontinence
WO2010106543A2 (en) 2009-03-20 2010-09-23 Proarc Medical Ltd. Methods and devices for urethral treatment
US9125716B2 (en) 2009-04-17 2015-09-08 Boston Scientific Scimed, Inc. Delivery sleeve for pelvic floor implants
US8277426B2 (en) 2009-09-30 2012-10-02 Wilcox Heather J Male urinary incontinence device
US9414902B2 (en) 2009-11-04 2016-08-16 Boston Scientific Scimed, Inc. Method for treating prolapse and incontinence
WO2011082330A1 (en) 2009-12-30 2011-07-07 Ams Research Corporation Implantable sling systems and methods
WO2011082287A1 (en) 2009-12-30 2011-07-07 Ams Research Corporation Implant systems with tensioning feedback
WO2011082220A1 (en) 2009-12-30 2011-07-07 Ams Research Corporation Elongate implant system and method for treating pelvic conditions
US9393091B2 (en) 2009-12-31 2016-07-19 Astora Women's Health, Llc Suture-less tissue fixation for implantable device
AU2011218197B2 (en) 2010-02-16 2015-05-21 Boston Scientific Scimed, Inc. Bioabsorbable mesh for surgical implants
US9445881B2 (en) 2010-02-23 2016-09-20 Boston Scientific Scimed, Inc. Surgical articles and methods
CA2789786C (en) 2010-02-23 2019-04-16 Ams Research Corporation Surgical articles and methods
US10028813B2 (en) 2010-07-22 2018-07-24 Boston Scientific Scimed, Inc. Coated pelvic implant device and method
US8684908B2 (en) 2010-08-26 2014-04-01 Ethicon, Inc. Centering aid for implantable sling
US8911348B2 (en) 2010-09-02 2014-12-16 Boston Scientific Scimed, Inc. Pelvic implants and methods of implanting the same
CN105769378B (en) * 2010-10-06 2017-11-28 Ams研究公司 For treating female pelvis illness, there is the graft of absorbability and nonabsorable feature
US9271754B2 (en) 2010-12-16 2016-03-01 Boston Scientific Scimed, Inc. Movable curved needle for delivering implants and methods of delivering implants
US9572648B2 (en) 2010-12-21 2017-02-21 Justin M. Crank Implantable slings and anchor systems
US9381075B2 (en) 2011-01-31 2016-07-05 Boston Scientific Scimed, Inc. Deflection member for delivering implants and methods of delivering implants
US9125717B2 (en) 2011-02-23 2015-09-08 Ams Research Corporation Implant tension adjustment system and method
WO2012123950A2 (en) 2011-03-17 2012-09-20 Proarc Medical Ltd. Methods and devices for urethral
WO2012129316A1 (en) 2011-03-22 2012-09-27 Applied Medical Resources Corporation Method of making medical tubing having drainage holes
US8808162B2 (en) 2011-03-28 2014-08-19 Ams Research Corporation Implants, tools, and methods for treatment of pelvic conditions
US20120253108A1 (en) 2011-03-28 2012-10-04 Fischer Brian G Implants, tools, and methods for treatment of pelvic conditions
US9492259B2 (en) 2011-03-30 2016-11-15 Astora Women's Health, Llc Expandable implant system
US20120277583A1 (en) 2011-04-29 2012-11-01 Pneumoflex Systems, Llc System and method for testing the gastric valve
US9232917B2 (en) 2011-04-29 2016-01-12 Pneumoflex Systems, Llc Urinary catheter system for diagnosing a physiological abnormality such as stress urinary incontinence
US10058240B2 (en) 2011-06-29 2018-08-28 Boston Scientific Scimed, Inc. Systems, implants, tools, and methods for treatments of pelvic conditions
US9351723B2 (en) 2011-06-30 2016-05-31 Astora Women's Health, Llc Implants, tools, and methods for treatments of pelvic conditions
US20130006049A1 (en) 2011-06-30 2013-01-03 Alexander James A Implants, tools, and methods for treatments of pelvic conditions
US9414903B2 (en) 2011-07-22 2016-08-16 Astora Women's Health, Llc Pelvic implant system and method
EP2734148B1 (en) 2011-07-22 2019-06-05 Boston Scientific Scimed, Inc. Pelvic implant system
US9492191B2 (en) 2011-08-04 2016-11-15 Astora Women's Health, Llc Tools and methods for treatment of pelvic conditions
US20130035555A1 (en) 2011-08-05 2013-02-07 Alexander James A Systems, implants, tools, and methods for treatment of pelvic conditions
US10098721B2 (en) 2011-09-01 2018-10-16 Boston Scientific Scimed, Inc. Pelvic implant needle system and method
US9808330B2 (en) * 2011-09-02 2017-11-07 Boston Scientific Scimed, Inc. Bodily implant with tension indicator
US9345472B2 (en) 2011-09-02 2016-05-24 Boston Scientific Scimed, Inc. Multi-arm tool for delivering implants and methods thereof
USD721175S1 (en) 2011-09-08 2015-01-13 Ams Research Corporation Backers for surgical indicators
USD721807S1 (en) 2011-09-08 2015-01-27 Ams Research Corporation Surgical indicators
USD736382S1 (en) 2011-09-08 2015-08-11 Ams Research Corporation Surgical indicator with backers
US9168120B2 (en) 2011-09-09 2015-10-27 Boston Scientific Scimed, Inc. Medical device and methods of delivering the medical device
US10265152B2 (en) 2011-10-13 2019-04-23 Boston Scientific Scimed, Inc. Pelvic implant sizing systems and methods
DE202012006023U1 (en) * 2012-06-22 2013-10-15 Feg Textiltechnik Forschungs- Und Entwicklungsgesellschaft Mbh Ligamentous structures for augmentation of a ligament
US9320586B2 (en) 2012-07-02 2016-04-26 Ethicon, Inc. Surgical implant for treating pelvic organ prolapse conditions
US10039627B2 (en) 2013-03-11 2018-08-07 Boston Scientific Scimed, Inc. Medical device and method of delivering the medical device
US9814555B2 (en) 2013-03-12 2017-11-14 Boston Scientific Scimed, Inc. Medical device for pelvic floor repair and method of delivering the medical device
EP2967819B1 (en) 2013-03-14 2021-04-28 Proarc Medical Ltd. Devices for urethral treatment
US9757221B2 (en) 2013-09-16 2017-09-12 Boston Scientific Scimed, Inc. Medical device and method of making the same
US9962251B2 (en) 2013-10-17 2018-05-08 Boston Scientific Scimed, Inc. Devices and methods for delivering implants
CN105769380B (en) * 2016-05-30 2017-09-22 周建 Fundus of bladder support arm and method for implantation in pelvis
CN115361991A (en) 2020-01-30 2022-11-18 兰巴姆医疗技术有限公司 Catheter prosthesis
CN114286646B (en) 2020-08-03 2024-03-08 泰利福生命科学有限公司 Handle and cassette system for medical intervention

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785640A (en) * 1996-05-23 1998-07-28 Kresch; Arnold J. Method for treating female incontinence
WO2000027304A1 (en) * 1998-11-10 2000-05-18 Sofradim Production Suspension device for treating prolapsus and urinary incontinence
WO2001006951A1 (en) * 1999-07-27 2001-02-01 Angiologica B.M. S.R.L. Corrective mesh for body tissues
US20020028980A1 (en) * 2000-09-07 2002-03-07 American Medical Systems Implantable article and method
WO2002058563A1 (en) * 2001-01-23 2002-08-01 American Medical Systems, Inc. Implantable sling
FR2824257A1 (en) * 2001-05-07 2002-11-08 Bernard Guerquin INTRA-VAGINAL DEVICE FOR THE PREVENTION OF FEMALE URINARY INCONTINENCE DURING EXERCISE

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3054406A (en) * 1958-10-17 1962-09-18 Phillips Petroleum Co Surgical mesh
US3789828A (en) 1972-09-01 1974-02-05 Heyer Schulte Corp Urethral prosthesis
US4019499A (en) 1976-04-22 1977-04-26 Heyer-Schulte Corporation Compression implant for urinary incontinence
US4452245A (en) * 1980-06-06 1984-06-05 Usher Francis C Surgical mesh and method
US4386601A (en) 1981-08-12 1983-06-07 Medical Engineering Corporation Artificial sphincter
US4522128A (en) * 1983-01-10 1985-06-11 Regents Of The University Of Minnesota Switch mechanism
US4552128A (en) 1983-12-29 1985-11-12 Haber Terry M Elastomechanical sphincter
US4587954A (en) 1983-12-29 1986-05-13 Habley Medical Technology Corporation Elastomeric prosthetic sphincter
US4682583A (en) 1984-04-13 1987-07-28 Burton John H Inflatable artificial sphincter
US4878889A (en) 1988-06-24 1989-11-07 American Medical Systems, Inc. Artificial sphincter device
US4994020A (en) 1989-07-21 1991-02-19 American Medical Systems, Inc. Implantable artificial sphincter system
US4994019A (en) * 1989-07-28 1991-02-19 Micro-Magnetics, Inc. Magnetic occluding device
US5041128A (en) 1989-09-27 1991-08-20 United States Sirgical Corporation Combined surgical needle-suture device possessing an integrated suture cut-off feature
US5163897A (en) 1989-10-25 1992-11-17 Lester Persky Incontinent prothesis and method
US5041129A (en) * 1990-07-02 1991-08-20 Acufex Microsurgical, Inc. Slotted suture anchor and method of anchoring a suture
US5520606A (en) 1990-10-18 1996-05-28 Schoolman; Arnold Mechanical urinary sphincter device
US5292328A (en) * 1991-10-18 1994-03-08 United States Surgical Corporation Polypropylene multifilament warp knitted mesh and its use in surgery
ATE176998T1 (en) * 1991-12-03 1999-03-15 Boston Scient Ireland Ltd INSTRUMENT FOR PASSING A SEWING THREAD
BR9302774A (en) 1993-07-06 1995-02-14 Antoine Jean Henri Robert Adjustable peri-urethral expander
DE19511998A1 (en) 1995-03-31 1996-10-02 Eska Medical Gmbh & Co Controller for discharge of urine from urethra
DE19515394C1 (en) * 1995-04-26 1996-05-23 Roland Man Druckmasch Producing surface structure for printing machine cylinder
DE19544162C1 (en) * 1995-11-17 1997-04-24 Ethicon Gmbh Implant for suspension of the bladder in urinary incontinence in women
AU6329598A (en) * 1997-02-13 1998-09-08 Boston Scientific Ireland Limited, Barbados Head Office Stabilization sling for use in minimally invasive pelvic surgery
US5934283A (en) * 1997-04-15 1999-08-10 Uroplasty, Inc. Pubovaginal sling device
ES2149091B1 (en) 1998-03-10 2001-05-16 Gil Vernet Vila Jose Maria DEVICE FOR FIXING AND ADJUSTABLE SUPPORT AT HEIGHT OF INTERNAL ANATOMICAL ORGANS.
US6319264B1 (en) * 1998-04-03 2001-11-20 Bionx Implants Oy Hernia mesh
US6382214B1 (en) 1998-04-24 2002-05-07 American Medical Systems, Inc. Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
US6258098B1 (en) 1998-05-08 2001-07-10 William N. Taylor Stent placement and removal system
AU737877B2 (en) 1998-05-21 2001-09-06 Christopher J. Walshe A tissue anchor system
ES2252981T3 (en) 1998-10-01 2006-05-16 Burger, Nicolaas Daniel Lombard DISTENSIBLE SUSPENSION DEVICE FOR URINARY INCONTINENCE.
WO2000049969A1 (en) 1999-02-22 2000-08-31 Bruno Pregenzer Implantable actuating mechanism
WO2000072764A1 (en) * 1999-05-28 2000-12-07 The Board Of Trustees Of The Leland Stanford Junior University Anastomosis system and methods for use
EP1581162B1 (en) 1999-06-09 2011-04-20 Ethicon, Inc. Apparatus for adjusting flexible areal polymer implants
US6306079B1 (en) 1999-12-07 2001-10-23 Arnaldo F. Trabucco Mesh pubovaginal sling
FR2802798B1 (en) * 1999-12-22 2002-02-01 Promedon S A PAD STRAP FOR THE TREATMENT OF URINARY INCONTINENCE
US6406423B1 (en) * 2000-01-21 2002-06-18 Sofradim Production Method for surgical treatment of urinary incontinence and device for carrying out said method
US6425924B1 (en) * 2000-03-31 2002-07-30 Ethicon, Inc. Hernia repair prosthesis
DE60140886D1 (en) * 2000-09-26 2010-02-04 Ethicon Inc SURGICAL APPARATUS FOR DISPENSING A SLING IN THE TREATMENT OF HARNESS INCONTINENCE IN WOMEN
US20020128670A1 (en) 2000-11-22 2002-09-12 Ulf Ulmsten Surgical instrument and method for treating female urinary incontinence
US7229453B2 (en) 2001-01-23 2007-06-12 Ams Research Corporation Pelvic floor implant system and method of assembly
US20020161382A1 (en) 2001-03-29 2002-10-31 Neisz Johann J. Implant inserted without bone anchors
US20020147382A1 (en) 2001-01-23 2002-10-10 Neisz Johann J. Surgical articles and methods
US6652450B2 (en) 2001-01-23 2003-11-25 American Medical Systems, Inc. Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
US6602260B2 (en) 2001-02-02 2003-08-05 Ams Research Corporation Powered bone screw device
EP1913896B1 (en) 2001-03-09 2012-12-26 Boston Scientific Limited Method for making a medical sling
US6755781B2 (en) 2001-07-27 2004-06-29 Scimed Life Systems, Inc. Medical slings
US6648921B2 (en) 2001-10-03 2003-11-18 Ams Research Corporation Implantable article
PT1487377E (en) * 2002-03-01 2012-11-23 Ethicon Inc Apparatus for treating pelvic organ prolapses in female patients
KR20050010765A (en) * 2002-05-07 2005-01-28 에이엠에스 리써치 코오포레이션 Urethral prosthesis with tensioning member
WO2004016196A2 (en) 2002-08-14 2004-02-26 Boston Scientific Limited Systems, methods and devices relating to delivery of medical implants

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785640A (en) * 1996-05-23 1998-07-28 Kresch; Arnold J. Method for treating female incontinence
WO2000027304A1 (en) * 1998-11-10 2000-05-18 Sofradim Production Suspension device for treating prolapsus and urinary incontinence
WO2001006951A1 (en) * 1999-07-27 2001-02-01 Angiologica B.M. S.R.L. Corrective mesh for body tissues
US20020028980A1 (en) * 2000-09-07 2002-03-07 American Medical Systems Implantable article and method
WO2002058563A1 (en) * 2001-01-23 2002-08-01 American Medical Systems, Inc. Implantable sling
WO2002062237A1 (en) * 2001-01-23 2002-08-15 American Medical Systems, Inc. Surgical sling delivery system
FR2824257A1 (en) * 2001-05-07 2002-11-08 Bernard Guerquin INTRA-VAGINAL DEVICE FOR THE PREVENTION OF FEMALE URINARY INCONTINENCE DURING EXERCISE

Cited By (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8568488B2 (en) 2001-08-27 2013-10-29 Boston Scientific Scimed, Inc. Satiation devices and methods
US7892292B2 (en) 2001-08-27 2011-02-22 Synecor, Llc Positioning tools and methods for implanting medical devices
US7111627B2 (en) 2001-08-27 2006-09-26 Synecor, Llc Satiation devices and methods
US7121283B2 (en) 2001-08-27 2006-10-17 Synecor, Llc Satiation devices and methods
US9872786B2 (en) 2001-08-27 2018-01-23 Boston Scientific Scimed, Inc. Gastro-esophageal implants
US7354454B2 (en) 2001-08-27 2008-04-08 Synecor, Llc Satiation devices and methods
US9844453B2 (en) 2001-08-27 2017-12-19 Boston Scientific Scimed, Inc. Positioning tools and methods for implanting medical devices
US9788984B2 (en) 2001-08-27 2017-10-17 Boston Scientific Scimed, Inc. Satiation devices and methods
US10080677B2 (en) 2001-08-27 2018-09-25 Boston Scientific Scimed, Inc. Satiation devices and methods
US7833280B2 (en) 2001-08-27 2010-11-16 Barosense, Inc. Satiation devices and methods
US7981162B2 (en) 2001-08-27 2011-07-19 Barosense, Inc. Satiation devices and methods
US8337566B2 (en) 2002-04-08 2012-12-25 Barosense, Inc. Method and apparatus for modifying the exit orifice of a satiation pouch
US7146984B2 (en) 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US8029455B2 (en) 2003-01-16 2011-10-04 Barosense, Inc. Satiation pouches and methods of use
US10098773B2 (en) 2004-04-26 2018-10-16 Boston Scientific Scimed, Inc. Restrictive and/or obstructive implant for inducing weight loss
US7896798B2 (en) 2004-08-04 2011-03-01 Ami Agency For Medical Innovations Gmbh Implant for treatment of male urinary stress incontinence
WO2006012653A1 (en) * 2004-08-04 2006-02-09 Ami Agency For Medical Innovations Gmbh Implant for treatment of male urinary stress incontinence
AU2005269231B2 (en) * 2004-08-04 2011-02-24 Ami Agency For Medical Innovations Gmbh Implant for treatment of male urinary stress incontinence
WO2006025950A1 (en) * 2004-08-30 2006-03-09 Boston Scientific Scimed, Inc. Urethral sealing method and device
US8105317B2 (en) 2004-08-30 2012-01-31 Boston Scientific Scimed, Inc. Urethral sealing method and device
JP2011177521A (en) * 2005-04-30 2011-09-15 Coloplast As Implantable sling for treatment of incontinence and method of using the same
JP2008541792A (en) * 2005-04-30 2008-11-27 コロプラスト アクティーゼルスカブ Implantable sling for the treatment of incontinence and how to use this sling
US10299796B2 (en) 2005-10-03 2019-05-28 Boston Scientific Scimed, Inc. Endoscopic plication devices and methods
US9055942B2 (en) 2005-10-03 2015-06-16 Boston Scienctific Scimed, Inc. Endoscopic plication devices and methods
US9687334B2 (en) 2006-09-02 2017-06-27 Boston Scientific Scimed, Inc. Intestinal sleeves and associated deployment systems and methods
US8109895B2 (en) 2006-09-02 2012-02-07 Barosense, Inc. Intestinal sleeves and associated deployment systems and methods
US9314361B2 (en) 2006-09-15 2016-04-19 Boston Scientific Scimed, Inc. System and method for anchoring stomach implant
US9545249B2 (en) 2007-07-18 2017-01-17 Boston Scientific Scimed, Inc. Overtube introducer for use in endoscopic bariatric surgery
US10537456B2 (en) 2007-07-18 2020-01-21 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US7909223B2 (en) 2008-03-18 2011-03-22 Barosense, Inc. Endoscopic stapling devices and methods
US7909222B2 (en) 2008-03-18 2011-03-22 Barosense, Inc. Endoscopic stapling devices and methods
US7708181B2 (en) 2008-03-18 2010-05-04 Barosense, Inc. Endoscopic stapling devices and methods
US7721932B2 (en) 2008-03-18 2010-05-25 Barosense, Inc. Endoscopic stapling devices and methods
US7909219B2 (en) 2008-03-18 2011-03-22 Barosense, Inc. Endoscopic stapling devices and methods
US7913892B2 (en) 2008-03-18 2011-03-29 Barosense, Inc. Endoscopic stapling devices and methods
US7922062B2 (en) 2008-03-18 2011-04-12 Barosense, Inc. Endoscopic stapling devices and methods
US9636114B2 (en) 2008-03-18 2017-05-02 Boston Scientific Scimed, Inc. Endoscopic stapling devices
US8020741B2 (en) 2008-03-18 2011-09-20 Barosense, Inc. Endoscopic stapling devices and methods
US10368862B2 (en) 2008-11-10 2019-08-06 Boston Scientific Scimed, Inc. Multi-fire stapling methods
US11202627B2 (en) 2008-11-10 2021-12-21 Boston Scientific Scimed, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
US9451956B2 (en) 2008-11-10 2016-09-27 Boston Scientific Scimed, Inc. Multi-fire stapling systems
US7934631B2 (en) 2008-11-10 2011-05-03 Barosense, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
US8961539B2 (en) 2009-05-04 2015-02-24 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US11351050B2 (en) 2010-06-13 2022-06-07 Synerz Medical, Inc. Intragastric device for treating obesity
US11135078B2 (en) 2010-06-13 2021-10-05 Synerz Medical, Inc. Intragastric device for treating obesity
US11596538B2 (en) 2010-06-13 2023-03-07 Synerz Medical, Inc. Intragastric device for treating obesity
US10413436B2 (en) 2010-06-13 2019-09-17 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10512557B2 (en) 2010-06-13 2019-12-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US11607329B2 (en) 2010-06-13 2023-03-21 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US9241779B2 (en) 2012-11-02 2016-01-26 Coloplast A/S Male incontinence treatment system
US10111651B2 (en) 2012-11-02 2018-10-30 Coloplast A/S System and method of anchoring support material to tissue
US9480546B2 (en) 2013-08-05 2016-11-01 Coloplast A/S Hysteropexy mesh apparatuses and methods
US9522000B2 (en) 2013-11-08 2016-12-20 Coloplast A/S System and a method for surgical suture fixation
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity

Also Published As

Publication number Publication date
EP1503695A2 (en) 2005-02-09
US20160045297A1 (en) 2016-02-18
US20100240948A1 (en) 2010-09-23
US7998055B2 (en) 2011-08-16
US9615905B2 (en) 2017-04-11
AU2003234212A1 (en) 2003-11-11
US20110257471A1 (en) 2011-10-20
US20150018603A1 (en) 2015-01-15
US7753839B2 (en) 2010-07-13
US20030216814A1 (en) 2003-11-20
US7198597B2 (en) 2007-04-03
JP2005524484A (en) 2005-08-18
BR0309802A (en) 2005-02-09
KR20050010765A (en) 2005-01-28
US9179993B2 (en) 2015-11-10
US20050027160A1 (en) 2005-02-03
CA2483124A1 (en) 2003-11-20
WO2003094784A3 (en) 2004-05-13
US8845514B2 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
US9615905B2 (en) Male urethral prosthesis with tensioning member
US7273448B2 (en) Male urethral prosthesis
AU2019201115B2 (en) Surgical implant system and method
US6042536A (en) Bladder sling
US8597172B2 (en) Tubular implantable sling and related delivery systems, methods and devices
EP2242446B1 (en) Partial cuff
US20040215054A1 (en) Male urethral prosthesis
JP5860102B2 (en) Implants and methods with minimal invasion
WO2004096087A1 (en) Male urethral sphincter prosthesis
AU2015202916B2 (en) Minimally invasive implant and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003234212

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020047017005

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2483124

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003728522

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004502874

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 1020047017005

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003728522

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003728522

Country of ref document: EP